Quality, innovation, and value for money: NICE and the British National Health Service
- PMID: 16304076
- DOI: 10.1001/jama.294.20.2618
Quality, innovation, and value for money: NICE and the British National Health Service
Abstract
The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into account both clinical effectiveness and cost-effectiveness. This article describes how NICE has responded to the challenge and considers whether its experience of balancing quality, innovation, and value for money holds policy lessons for the United States.
Comment in
-
Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.JAMA. 2005 Nov 23;294(20):2630-2. doi: 10.1001/jama.294.20.2630. JAMA. 2005. PMID: 16304078 No abstract available.
-
Cost-effectiveness analysis in the United States.JAMA. 2006 Jun 21;295(23):2722; author reply 2722-3. doi: 10.1001/jama.295.23.2722-a. JAMA. 2006. PMID: 16788125 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
